Do analysts rate IVP or ORIS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inspire Veterinary Partners 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Oriental Rise 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation and earnings, IVP or ORIS?

Oriental Rise has lower revenue, but higher earnings than Inspire Veterinary Partners. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Inspire Veterinary Partners $15.56M 0.09 -$14.26M -$2.20 N/A Oriental Rise $12.22M 0.04 $680K N/A N/A

Do analysts rate RKDA or ORIS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Arcadia Biosciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Oriental Rise 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings & valuation, RKDA or ORIS?

Oriental Rise has higher revenue and earnings than Arcadia Biosciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Arcadia Biosciences $4.86M 0.30 -$2.34M -$5.73 N/A Oriental Rise $12.22M 0.04 $680K N/A N/A

Do analysts rate NCRA or ORIS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nocera 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Oriental Rise 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation & earnings, NCRA or ORIS?

Oriental Rise has lower revenue, but higher earnings than Nocera. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Nocera $13.63M 0.17 -$2.84M -$6.60 N/A Oriental Rise $12.22M 0.04 $680K N/A N/A

Is NCRA or ORIS more profitable?

Oriental Rise has a net margin of 0.00% compared to Nocera's net margin of -44.02%. Oriental Rise's return on equity of 0.00% beat Nocera's return on equity. Company Net Margins Return on Equity Return on Assets Nocera -44.02% -207.32% -47.66% Oriental Rise N/A N/A N/A

Do analysts prefer EDBL or ORIS?

Edible Garden presently has a consensus price target of $45.00, indicating a potential upside of 1,150.00%. Given Edible Garden's stronger consensus rating and higher possible upside, equities research analysts plainly believe Edible Garden is more favorable than Oriental Rise. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Edible Garden 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Oriental Rise 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation and earnings, EDBL or ORIS?

Oriental Rise has lower revenue, but higher earnings than Edible Garden. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Edible Garden $12.81M 0.03 -$17.33M -$4.94 thousand N/A Oriental Rise $12.22M 0.04 $680K N/A N/A

Is EDBL or ORIS more profitable?

Oriental Rise has a net margin of 0.00% compared to Edible Garden's net margin of -131.59%. Company Net Margins Return on Equity Return on Assets Edible Garden -131.59% N/A -88.36% Oriental Rise N/A N/A N/A

Do analysts prefer YTEN or ORIS?

Given Yield10 Bioscience's higher probable upside, research analysts clearly believe Yield10 Bioscience is more favorable than Oriental Rise. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Yield10 Bioscience 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Oriental Rise 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings & valuation, YTEN or ORIS?

Oriental Rise has higher revenue and earnings than Yield10 Bioscience. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Yield10 Bioscience $60K 0.00 -$14.45M -$26.12 N/A Oriental Rise $12.22M 0.04 $680K N/A N/A

Is YTEN or ORIS more profitable?

Company Net Margins Return on Equity Return on Assets Yield10 Bioscience N/A N/A -296.08% Oriental Rise N/A N/A N/A

Oriental Rise (ORIS) Competitors

$1.83 0.00 (0.00%)

As of 07/20/2026

Compare

ORIS vs. IVP, RKDA, NCRA, EDBL, and YTEN

Should you buy Oriental Rise stock or one of its competitors? MarketBeat compares Oriental Rise with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Oriental Rise include Inspire Veterinary Partners (IVP), Arcadia Biosciences (RKDA), Nocera (NCRA), Edible Garden (EDBL), and Yield10 Bioscience (YTEN). These companies are all part of the "agriculture" industry.

How does Oriental Rise compare to Inspire Veterinary Partners?

Inspire Veterinary Partners (NASDAQ:IVP) and Oriental Rise (NASDAQ:ORIS) are both small-cap consumer staples companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, media sentiment, risk, earnings and valuation.

Oriental Rise has lower revenue, but higher earnings than Inspire Veterinary Partners.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspire Veterinary Partners	$15.56M	0.09	-$14.26M	-$2.20	N/A
Oriental Rise	$12.22M	0.04	$680K	N/A	N/A

4.8% of Inspire Veterinary Partners shares are held by institutional investors. 6.4% of Inspire Veterinary Partners shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspire Veterinary Partners	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Oriental Rise	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Inspire Veterinary Partners had 1 more articles in the media than Oriental Rise. MarketBeat recorded 1 mentions for Inspire Veterinary Partners and 0 mentions for Oriental Rise. Inspire Veterinary Partners' average media sentiment score of 1.19 beat Oriental Rise's score of 0.00 indicating that Inspire Veterinary Partners is being referred to more favorably in the media.

Company	Overall Sentiment
Inspire Veterinary Partners	Positive
Oriental Rise	Neutral

Oriental Rise has a net margin of 0.00% compared to Inspire Veterinary Partners' net margin of -76.75%. Oriental Rise's return on equity of 0.00% beat Inspire Veterinary Partners' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inspire Veterinary Partners	-76.75%	-520.34%	-55.79%
Oriental Rise	N/A	N/A	N/A

Inspire Veterinary Partners has a beta of -0.49, meaning that its stock price is 149% less volatile than the broader market. Comparatively, Oriental Rise has a beta of 1.54, meaning that its stock price is 54% more volatile than the broader market.

Summary

Inspire Veterinary Partners beats Oriental Rise on 6 of the 11 factors compared between the two stocks.

How does Oriental Rise compare to Arcadia Biosciences?

Arcadia Biosciences (NASDAQ:RKDA) and Oriental Rise (NASDAQ:ORIS) are both small-cap agriculture companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, institutional ownership, analyst recommendations, profitability, risk and earnings.

In the previous week, Arcadia Biosciences' average media sentiment score of 0.00 equaled Oriental Rise'saverage media sentiment score.

Company	Overall Sentiment
Arcadia Biosciences	Neutral
Oriental Rise	Neutral

Oriental Rise has a net margin of 0.00% compared to Arcadia Biosciences' net margin of -195.94%. Oriental Rise's return on equity of 0.00% beat Arcadia Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Arcadia Biosciences	-195.94%	-113.73%	-68.47%
Oriental Rise	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Arcadia Biosciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Oriental Rise	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Oriental Rise has higher revenue and earnings than Arcadia Biosciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Arcadia Biosciences	$4.86M	0.30	-$2.34M	-$5.73	N/A
Oriental Rise	$12.22M	0.04	$680K	N/A	N/A

17.7% of Arcadia Biosciences shares are owned by institutional investors. 8.2% of Arcadia Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Arcadia Biosciences has a beta of 0.54, meaning that its share price is 46% less volatile than the broader market. Comparatively, Oriental Rise has a beta of 1.54, meaning that its share price is 54% more volatile than the broader market.

Summary

Oriental Rise beats Arcadia Biosciences on 6 of the 9 factors compared between the two stocks.

How does Oriental Rise compare to Nocera?

Nocera (NASDAQ:NCRA) and Oriental Rise (NASDAQ:ORIS) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, media sentiment, dividends and earnings.

Oriental Rise has a net margin of 0.00% compared to Nocera's net margin of -44.02%. Oriental Rise's return on equity of 0.00% beat Nocera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nocera	-44.02%	-207.32%	-47.66%
Oriental Rise	N/A	N/A	N/A

Nocera has a beta of 1.89, meaning that its share price is 89% more volatile than the broader market. Comparatively, Oriental Rise has a beta of 1.54, meaning that its share price is 54% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nocera	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Oriental Rise	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

1.3% of Nocera shares are owned by institutional investors. 5.2% of Nocera shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Oriental Rise has lower revenue, but higher earnings than Nocera.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nocera	$13.63M	0.17	-$2.84M	-$6.60	N/A
Oriental Rise	$12.22M	0.04	$680K	N/A	N/A

In the previous week, Nocera had 1 more articles in the media than Oriental Rise. MarketBeat recorded 1 mentions for Nocera and 0 mentions for Oriental Rise. Nocera's average media sentiment score of 0.36 beat Oriental Rise's score of 0.00 indicating that Nocera is being referred to more favorably in the media.

Company	Overall Sentiment
Nocera	Neutral
Oriental Rise	Neutral

Summary

Nocera beats Oriental Rise on 7 of the 11 factors compared between the two stocks.

How does Oriental Rise compare to Edible Garden?

Edible Garden (NASDAQ:EDBL) and Oriental Rise (NASDAQ:ORIS) are both small-cap consumer staples companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, valuation, media sentiment, analyst recommendations and institutional ownership.

Edible Garden presently has a consensus price target of $45.00, indicating a potential upside of 1,150.00%. Given Edible Garden's stronger consensus rating and higher possible upside, equities research analysts plainly believe Edible Garden is more favorable than Oriental Rise.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Edible Garden	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Oriental Rise	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

13.0% of Edible Garden shares are owned by institutional investors. 0.8% of Edible Garden shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Oriental Rise has a net margin of 0.00% compared to Edible Garden's net margin of -131.59%.

Company	Net Margins	Return on Equity	Return on Assets
Edible Garden	-131.59%	N/A	-88.36%
Oriental Rise	N/A	N/A	N/A

Edible Garden has a beta of 1.7, indicating that its share price is 70% more volatile than the broader market. Comparatively, Oriental Rise has a beta of 1.54, indicating that its share price is 54% more volatile than the broader market.

Oriental Rise has lower revenue, but higher earnings than Edible Garden.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Edible Garden	$12.81M	0.03	-$17.33M	-$4.94 thousand	N/A
Oriental Rise	$12.22M	0.04	$680K	N/A	N/A

In the previous week, Edible Garden had 3 more articles in the media than Oriental Rise. MarketBeat recorded 3 mentions for Edible Garden and 0 mentions for Oriental Rise. Edible Garden's average media sentiment score of 0.69 beat Oriental Rise's score of 0.00 indicating that Edible Garden is being referred to more favorably in the media.

Company	Overall Sentiment
Edible Garden	Positive
Oriental Rise	Neutral

Summary

Edible Garden beats Oriental Rise on 9 of the 13 factors compared between the two stocks.

How does Oriental Rise compare to Yield10 Bioscience?

Yield10 Bioscience (NASDAQ:YTEN) and Oriental Rise (NASDAQ:ORIS) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, earnings, analyst recommendations, valuation and institutional ownership.

Company	Net Margins	Return on Equity	Return on Assets
Yield10 Bioscience	N/A	N/A	-296.08%
Oriental Rise	N/A	N/A	N/A

Given Yield10 Bioscience's higher probable upside, research analysts clearly believe Yield10 Bioscience is more favorable than Oriental Rise.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Yield10 Bioscience	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Oriental Rise	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Oriental Rise has higher revenue and earnings than Yield10 Bioscience.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Yield10 Bioscience	$60K	0.00	-$14.45M	-$26.12	N/A
Oriental Rise	$12.22M	0.04	$680K	N/A	N/A

Yield10 Bioscience has a beta of 1.48, indicating that its share price is 48% more volatile than the broader market. Comparatively, Oriental Rise has a beta of 1.54, indicating that its share price is 54% more volatile than the broader market.

In the previous week, Yield10 Bioscience had 1 more articles in the media than Oriental Rise. MarketBeat recorded 1 mentions for Yield10 Bioscience and 0 mentions for Oriental Rise. Yield10 Bioscience's average media sentiment score of 0.00 equaled Oriental Rise'saverage media sentiment score.

Company	Overall Sentiment
Yield10 Bioscience	Neutral
Oriental Rise	Neutral

4.9% of Yield10 Bioscience shares are owned by institutional investors. 6.1% of Yield10 Bioscience shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Oriental Rise beats Yield10 Bioscience on 5 of the 9 factors compared between the two stocks.

Get Oriental Rise News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ORIS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ORIS vs. The Competition

Export

Metric	Oriental Rise	FOOD Industry	Staples Sector	NASDAQ Exchange
Market Cap	$503K	$7.88B	$16.62B	$12.31B
Dividend Yield	N/A	3.71%	3.29%	9.67%
P/E Ratio	N/A	16.41	25.67	24.18
Price / Sales	0.04	1.23	44.37	79.19
Price / Cash	0.27	9.91	16.78	59.37
Price / Book	0.01	2.79	5.86	6.25
Net Income	$680K	$149.81M	$657.22M	$331.66M
7 Day Performance	N/A	1.33%	0.83%	-1.33%
1 Month Performance	-24.38%	2.31%	2.03%	-1.75%
1 Year Performance	-85.70%	-14.97%	-13.28%	18.04%

Oriental Rise Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ORIS Oriental Rise	N/A	$1.83 flat	N/A	N/A	$503K	$12.22M	N/A	N/A
IVP Inspire Veterinary Partners	0.3372 of 5 stars	$0.03 flat	N/A	N/A	$1.41M	$15.56M	N/A	156
RKDA Arcadia Biosciences	0.6947 of 5 stars	$0.62 -0.7%	N/A	-84.8%	$1.36M	$4.86M	N/A	60	Positive News
NCRA Nocera	0.2774 of 5 stars	$1.45 -1.4%	N/A	-95.9%	$750K	$13.63M	N/A	10	Gap Down
EDBL Edible Garden	3.5808 of 5 stars	$3.48 -17.1%	$45.00 +1,193.1%	-99.7%	$510K	$12.81M	N/A	50	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ORIS) was last updated on 7/22/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Oriental Rise (ORIS) Competitors

ORIS vs. IVP, RKDA, NCRA, EDBL, and YTEN

How does Oriental Rise compare to Inspire Veterinary Partners?

Summary

How does Oriental Rise compare to Arcadia Biosciences?

Summary

How does Oriental Rise compare to Nocera?

Summary

How does Oriental Rise compare to Edible Garden?

Summary

How does Oriental Rise compare to Yield10 Bioscience?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ORIS vs. The Competition

Oriental Rise Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Oriental Rise (ORIS) Competitors

ORIS vs. IVP, RKDA, NCRA, EDBL, and YTEN

How does Oriental Rise compare to Inspire Veterinary Partners?

Which has better valuation and earnings, IVP or ORIS?

Do institutionals and insiders believe in IVP or ORIS?

Do analysts rate IVP or ORIS?

Does the media prefer IVP or ORIS?

Is IVP or ORIS more profitable?

Which has more risk & volatility, IVP or ORIS?

Summary

How does Oriental Rise compare to Arcadia Biosciences?

Does the media prefer RKDA or ORIS?

Is RKDA or ORIS more profitable?

Do analysts rate RKDA or ORIS?

Which has higher earnings & valuation, RKDA or ORIS?

Do insiders and institutionals believe in RKDA or ORIS?

Which has more risk and volatility, RKDA or ORIS?

Summary

How does Oriental Rise compare to Nocera?

Is NCRA or ORIS more profitable?

Which has more volatility and risk, NCRA or ORIS?

Do analysts rate NCRA or ORIS?

Do insiders & institutionals believe in NCRA or ORIS?

Which has preferable valuation & earnings, NCRA or ORIS?

Does the media prefer NCRA or ORIS?

Summary

How does Oriental Rise compare to Edible Garden?

Do analysts prefer EDBL or ORIS?

Do insiders and institutionals have more ownership in EDBL or ORIS?

Is EDBL or ORIS more profitable?

Which has more volatility and risk, EDBL or ORIS?

Which has stronger valuation and earnings, EDBL or ORIS?

Does the media prefer EDBL or ORIS?

Summary

How does Oriental Rise compare to Yield10 Bioscience?

Is YTEN or ORIS more profitable?

Do analysts prefer YTEN or ORIS?

Which has better earnings & valuation, YTEN or ORIS?

Which has more volatility & risk, YTEN or ORIS?

Does the media prefer YTEN or ORIS?

Do insiders & institutionals have more ownership in YTEN or ORIS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ORIS vs. The Competition

Oriental Rise Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools